Building a better understanding of the burden of disease in familial chylomicronemia syndrome
Author:
Affiliation:
1. UT Southwestern, IM Subspecialties Clinic, Texas, USA
2. Akcea Therapeutics, MA, USA
Funder
Akcea Therapeutics
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1251839
Reference10 articles.
1. Targeting APOC3 in the Familial Chylomicronemia Syndrome
2. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia
3. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1
4. Practice Guidelines in Acute Pancreatitis
5. Late mortality in patients with severe acute pancreatitis
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular;Clínica e Investigación en Arteriosclerosis;2024-05
2. SEA 2024 Standards for Global Control of Vascular Risk;Clínica e Investigación en Arteriosclerosis (English Edition);2024-05
3. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS);Atherosclerosis;2023-06
4. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28;Quality of Life Research;2022-10-31
5. Estándares SEA 2022 para el control global del riesgo cardiovascular;Clínica e Investigación en Arteriosclerosis;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3